Humira, Remicade, Similar Drugs May Increase Risk of New Onset Psoriasis: Study
Drugs like Humira and Remicade, designed to treat autoimmune disorders, may increase the risk of new onset psoriasis, according to the findings of a new study.
Tag Archives: Psoriasis
-
-
Tagrisso Side Effects Linked to Potentially Deadly Skin Reactions: Case Report
A case report warns of potentially extreme and deadly skin reactions linked to use of the cancer drug Tagrisso.
-
Air Pollution Exposure Linked To Psoriasis Flare-Ups In New Study
A new study links air pollution exposure to an increased risk of psoriasis flare ups.
-
Humira, Remicade, Linked To Serious Infection Risks in Psoriasis Patients: Study
The findings of a new study indicate Humira and Remicade can increase the risk of serious infections in patients with psoriasis.
-
Side Effects of Stelara May Trigger Severe Cardiovascular Events: Study
A new study warns that Stelara can significantly increase the risk of heart problems and strokes among patients already at a high risk of coronary events.
-
J&J Ads Contain Misleading Safety Stats On Tremfya, Novartis Lawsuit Claims
Novartis has filed a lawsuit against Johnson & Johnson claiming it is using misleading advertising to promote the psoriasis drug Tremfya, which omits critical safety data.
-
Stelara Cancer Rates Up to 15 Times Higher Than Other Psoriasis Drugs, ISMP Reports
A new ISMP report warns that the psoriasis drug Stelara appears to be linked to a high rate of cancer.
-
Enbrel, Humira Side Effects Caused More Injuries Than Any Other Drugs in 2014: Report
Humira and Enbrel were the drugs most linked to injury reports last year, including injection site reactions, infections and cases of cancer, according to a new report.
-
Dermatologists Prescribe Steroids For Psoriasis, Despite Guidelines: Study
A new study reveals that some dermatologists are prescribing steroids to psoriasis patients in defiance of medical guidelines on treating the skin condition.
-
Raptiva Recall Lawsuit Trial Over Fatal Infection Delayed
The first trial over claims that the recalled psoriasis drug Raptiva caused a fatal brain infection has been pushed back to June.
